Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
machine learning
Biotech
After $1B fundraise, Xaira breaks silence on AI work
Xaira’s Chief Operating Officer, Jeff Jonker, opened up to Fierce, divulging details about the biotech’s efforts in I&I research.
Gabrielle Masson
,
Darren Incorvaia
Mar 17, 2026 2:52pm
Fierce Pharma
Teva debuts innovation platform to parry key industry challenges
Nov 19, 2025 8:38am
Thermo Fisher launches biopsy test to assess lung rejection risk
Oct 9, 2025 10:50am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
PhaseV launches trial optimization software into CRO's services
Sep 10, 2025 12:54pm
GI-focused CRO boosts trial tech with adaptive software
Feb 3, 2025 11:40am